TXN$277.14-1.8%Cap: $252.2BP/E: 47.452w: [=========|-](Apr 25)
Setup
TXN reported Q1 2026 on April 24. EPS came in at $1.68 against a $1.37 consensus — a 22.6% beat that reverses a four-quarter monotonic miss trend (+20.2%, +5.8%, -0.4%, -2.9%, now +22.6%) and breaks the bear thesis going in. The stock is +20.6% over five sessions to $277.14, RSI 91. The question now is not whether the beat happened but whether any edge remains.
What the filing says
Revenue $4,825M, +19% YoY, +9% sequential. Gross margin 58.0% — first expansion (+120 bps YoY) after multi-year compression (68.8% FY22 to 57.0% FY25, a 1,180 bps decline). Embedded Processing operating margin 16.9% vs 6.2% prior year (+1,070 bps), explicitly attributed to LFAB ramp drag dissipating: management notes "as LFAB ramps, we expect Embedded to carry manufacturing costs that disproportionately benefit Embedded Processing operating profit."
Inventory 209 days vs 222 prior quarter and 241 peak. Capex $676M (-40% YoY); FCF TTM $4.35B (+154% YoY), 23.6% of revenue. CHIPS Act direct cash receipts $555M in Q1 alone, $2.9B receivable remaining — $4-5B incremental cash over the next five to six quarters. Depreciation $541M Q1 (annualized $2.16B) lands within the guided $2.2-2.4B range; volume beat enough to overcome the headwind that grounded the prior bear case.
Bear residuals: management added new MD&A language — "uncertainty related to broader macroeconomic dynamics remains." Buybacks cut to $158M from $653M Q1'25 (-76%), capital conservation ahead of the SLAB close. China end-customer revenue +24% YoY to 21% of total. No tariff-specific disclosure.
What the market thinks
Forward P/E roughly 40-43x at $277 vs analog peer median 25-30x and TXN five-year average 22x. The post-print rerating prices sustained cycle recovery, gross margin held above 57%, and SLAB accretion. Market-implied probability of continued beat trajectory runs ≈10pp above our worldview estimate; no edge on a direct long at current levels.
The cycle confirmation is not idiosyncratic. STM reported the same day (Apr 23) with an identical 16.9% Embedded operating margin and +800 bps YoY expansion — same mechanism, same magnitude. The full analog cohort moved together: TXN +20.6%, INTC +20.5%, ON +18.5%, MCHP +13.6%, STM +14.1%, NXPI +13.0%, MPWR +11.1%, ADI +7.6% over one week. SOXX and SMH at RSI 100. Apr 24 was a factor day, not a name-specific event.
Why the gap is small
The bear thesis had five sub-components. Four were directly invalidated by the print: margin compression (reversed), earnings deceleration (reversed), depreciation drag (absorbed), Embedded margin floor (cleared). One — China revenue exposure — remains open.
Peer commentary going back to early February was already telegraphing book-to-bill above 1, lead times tightening, and inventory normalization. The trade window was that February-March period when sell-side was still anchored to the 2024-2025 false-start pattern. By the time TXN printed Apr 24, every analog name had ripped 11-23% in a week. The signal is consensus.
Risks (ranked by impact)
- China pull-forward. ADI was the only peer to flag explicitly: "unusual behavior tariffs, where saw order acceleration... auto book-to-bill end under one." TXN, STM, MCHP, MPWR did not mention it. NXPI Q1 print (late April) is the next test. Confirmation would mean H2 2026 cliff for auto-heavy names; TXN's diversified mix is less exposed but not immune.
- RSI 91 mean reversion. Sector ETFs at RSI 100. New entries face technical and positioning headwinds.
- SLAB financing. $7.5B all-cash deal, financing "to be arranged." Buyback cuts confirm capital conservation but $4-5B new debt on existing $14B at current rates adds $200-250M annual interest post-close.
- Tariff escalation. TXN ships ≈50% of revenue to China per FY2025 disclosure. Any semiconductor-specific tariff action lands disproportionately here.
- Insider selling overhang. $25.8M coordinated selling Feb 2026 (CFO $15.9M plus five officers) preceded the print. Post-print insider behavior unknown.
Catalysts
- NXPI Q1 2026 print, late April / early May — auto pull-forward test
- MPWR Q1 2026 print, ~Apr 30 — data center analog follow-through
- TXN Q2 2026 earnings, late July — first read on cycle continuation
- SLAB deal close, expected H1 2027
What would change our mind
Bullish update if: NXPI denies pull-forward, MPWR data center revenue accelerates, TXN announces SLAB financing on terms below 5%, additional CHIPS Act tranches accelerate.
Bearish update if: NXPI confirms pull-forward, TXN Q2 guide sequential flat or below, gross margin compresses back below 57%, semiconductor-specific tariff action announced, post-print insider selling cluster detected.
The honest read: TXN itself has no edge here. The trade window was Feb-Mar peer commentary, harvested by anyone who acted before Apr 24. The PnL relevant to books holding analog exposure into the print is in adjacent positions — trimming extended names now that the binary event resolved upside, and NXPI as a conditional short setup contingent on the next print confirming pull-forward — not in adding TXN.
Evidence
| Evidence | Source | Credibility | LR |
|---|---|---|---|
| EPS $1.68 vs $1.37 consensus, breaks 4-Q miss trend | 10-Q 2026-04-24, Income Statement | 0.95 | 1.8 |
| GM 58.0% vs 56.8% YoY, first expansion after 1,180 bps compression | 10-Q 2026-04-24, MD&A Revenue | 0.95 | 1.5 |
| Embedded Processing margin 16.9% vs 6.2% YoY (+1,070 bps) | 10-Q 2026-04-24, Segment Reporting | 0.95 | 1.5 |
| FCF TTM $4.35B (+154%), capex -40% YoY ($676M Q1) | 10-Q 2026-04-24, Cash Flow Statement | 0.95 | 1.4 |
| Depreciation $541M Q1 absorbed within $2.2-2.4B guide | 10-Q 2026-04-24, MD&A | 0.95 | 1.4 |
| Inventory 209 days vs 222 prior Q vs 241 peak | 10-Q 2026-04-24, MD&A | 0.95 | 1.3 |
| CHIPS Act $555M Q1 direct cash, $2.9B receivable remaining | 10-Q 2026-04-24, Cash Flow + Balance Sheet | 0.95 | 1.3 |
| STM Q1 2026 identical 16.9% Embedded margin (+800 bps YoY) | STM Q1 2026 earnings release Apr 23 | 0.95 | 1.5 |
| Synchronized peer rally Apr 24 (8 names +7.6% to +20.6% 1W) | Market data Apr 25 | 0.95 | 1.3 |
| INTC Q1 2026: 6th consecutive quarter beat, DCAI +22% YoY | INTC Q1 2026 8-K Apr 23 | 0.95 | 1.4 |
| China end-customer +24% YoY to 21% of revenue, no tariff disclosure | 10-Q 2026-04-24, MD&A | 0.95 | 0.9 |
| ADI Q1 FY2026: "unusual behavior tariffs... book-to-bill end under one" | ADI Q1 FY26 earnings call Feb 18 | 0.95 | 1.0 |
| Buybacks $158M vs $653M (-76%), capital conservation pre-SLAB | 10-Q 2026-04-24, Cash Flow Statement | 0.95 | 0.95 |
| SLAB merger spread compressed from 69% (Feb) to 7.2% (Apr 25) | Market data Apr 25 | 0.95 | 1.4 |
| MD&A new language: "uncertainty related to broader macroeconomic dynamics remains" | 10-Q 2026-04-24, MD&A | 0.95 | 0.95 |
| Insider selling $25.8M Feb 2026 (CFO $15.9M plus 5 officers) | Form 4 filings Feb 5-17 | 0.95 | 0.8 |
| TXN forward P/E 40-43x vs analog peer median 25-30x, 5-yr avg 22x | Market data + cross-check | 0.85 | 0.9 |
// comments (0)